Glucocorticoid receptor gene variant in the 3′ untranslated region is associated with multiple measures of blood pressure

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 1, 2009, Pages 268-276

  Chung, Charles C ^a   Shimmin, Lawrence ^a   Natarajan, Sivamani ^a   Hanis, Craig L ^a   Boerwinkle, Eric ^a   Hixson, James E ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; MESSENGER RNA;

3' UNTRANSLATED REGION; AFRICAN AMERICAN; ANIMAL CELL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHROMOSOME 5; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EMBRYO; ETHNIC GROUP; EUROPEAN AMERICAN; EXON; FAMILY; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISPANIC; HOMEOSTASIS; HUMAN; HUMAN CELL; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULSE PRESSURE; RECEPTOR GENE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

EID: 58149392537     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1089     Document Type: Article

References (40)

1. Magiakou MA, Smyrnaki P, Chrousos GP 2006 Hypertension in Cushing's syndrome. Best Pract Res 20:467-482
2. Fishel RS, Eisenberg S, Shai SY, Redden RA, Bernstein KE, Berk BC 1995 Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension 25:343-349
3. Sato A, Suzuki H, Nakazato Y, Shibata H, Inagami T, Saruta T 1994 Increased expression of vascular angiotensin II type 1A receptor gene in glucocorticoid-induced hypertension. J Hypertens 12:511-516
4. Axelrod L 1983 Inhibition of prostacyclin production mediates permissive effect of glucocorticoids on vascular tone. Perturbations of this mechanism contribute to pathogenesis of Cushing's syndrome and Addison's disease. Lancet 1:904-906
5. Mitchell BM, Webb RC 2002 Impaired vasodilation and nitric oxide synthase activity in glucocorticoid-induced hypertension. Biol Res Nurs 4:16-21
6. Wallerath T, Witte K, Schafer SC, Schwarz PM, Prellwitz W, Wohlfart P, Kleinert H, Lehr HA, Lemmer B, Forstermann U 1999 Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA 96:13357-13362
7. Whitworth JA, Schyvens CG, Zhang Y, Andrews MC, Mangos GJ, Kelly JJ 2002 The nitric oxide system in glucocorticoid-induced hypertension. J Hypertens 20:1035-1043
8. Lin RC, Wang WY, Morris BJ 1999 Association and linkage analyses of glucocorticoid receptor gene markers in essential hypertension. Hypertension 34:1186-1192
9. Lin RC, Wang XL, Morris BJ 2003 Association of coronary artery disease with glucocorticoid receptor N363S variant. Hypertension 41:404-407
10. Rosmond R, Radulovic V, Holm G 2006 A brief update of glucocorticoid receptor variants and obesity risk. Ann NY Acad Sci 1083:153-164
11. Watt GC, Harrap SB, Foy CJ, Holton DW, Edwards HV, Davidson HR, Connor JM, Lever AF, Fraser R 1992 Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 10:473-482
12. van Rossum EF, Russcher H, Lamberts SW 2005 Genetic polymorphisms and multifactorial diseases: facts and fallacies revealed by the glucocorticoid receptor gene. Trends Endocrinol Metab 16:445-450
13. Shimmin LC, Natarajan S, Ibarguen H, Montasser M, Kim DK, Hanis CL, Boerwinkle E, Wadhwa PD, Hixson JE 2007 Corticotropin releasing hormone (CRH) gene variation: comprehensive resequencing for variant and molecular haplotype discovery in monosomic hybrid cell lines. DNA Seq 18:434-444
14. Douglas JA, Boehnke M, Gillanders E, Trent JM, Gruber SB 2001 Experimentally derived haplotypes substantially increase the efficiency of linkage disequilibrium studies. Nat Genet 28:361-364
15. Yan H, Papadopoulos N, Marra G, Perrera C, Jiricny J, Boland CR, Lynch HT, Chadwick RB, de la Chapelle A, Berg K, Eshleman JR, Yuan W, Markowitz S, Laken SJ, Lengauer C, Kinzler KW, Vogelstein B 2000 Conversion of diploidy to haploidy. Nature 403:723-724
16. 2002 Multi-center genetic study of hypertension: the Family Blood Pressure Program (FBPP). Hypertension 39:3-9
17. Tobler AR, Short S, Andersen MR, Paner TM, Briggs JC, Lambert SM, Wu PP, Wang Y, Spoonde AY, Koehler RT, Peyret N, Chen C, Broomer AJ, Ridzon DA, Zhou H, Hoo BS, Hayashibara KC, Leong LN, Ma CN, Rosenblum BB, Day JP, Ziegle JS, De La Vega FM, Rhodes MD, Hennessy KM, Wenz HM 2005 The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping. J Biomol Tech 16:398-406
18. Barrett JC, Fry B, Maller J, Daly MJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
19. Horvath S, Xu X, Laird NM 2001 The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 9:301-306
20. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM 2004 Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol 26:61-69
21. Benjamini Y, Hochberg Y 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289-300
22. Hawkins GA, Amelung PJ, Smith RS, Jongepier H, Howard TD, Koppelman GH, Meyers DA, Bleecker ER, Postma DS 2004 Identification of polymorphisms in the human glucocorticoid receptor gene (NR3C1) in a multi-racial asthma case and control screening panel. DNA Seq 15:167-173
23. Koyano S, Saito Y, Sai K, Kurose K, Ozawa S, Nakajima T, Matsumoto K, Saito H, Shirao K, Yoshida T, Minami H, Ohtsu A, Saijo N, Sawada J 2005 Novel genetic polymorphisms in the NR3C1 (glucocorticoid receptor) gene in a Japanese population. Drug Metab Pharmacokinet 20:79-84
24. Breslin MB, Geng CD, Vedeckis WV 2001 Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids. Mol Endocrinol 15:1381-1395
25. Nunez BS, Vedeckis WV 2002 Characterization of promoter 1B in the human glucocorticoid receptor gene. Mol Cell Endocrinol 189:191-199
26. Bodwell JE, Webster JC, Jewell CM, Cidlowski JA, Hu JM, Munck A 1998 Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. J Steroid Biochem Mol Biol 65:91-99
27. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH, Lamberts SW 1998 A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 83:144-151
28. Dobson MG, Redfern CP, Unwin N, Weaver JU 2001 The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity inmenand lack of association with other risk factors for coronary heart disease and diabetes mellitus. J Clin Endocrinol Metab 86:2270-2274
29. Lin RC, Wang XL, Dalziel B, Caterson ID, Morris BJ 2003 Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obes Res 11:802-808
30. Rosmond R, Bouchard C, Bjorntorp P 2001 Tsp509I polymorphism in exon 2 of the glucocorticoid receptor gene in relation to obesity and cortisol secretion: cohort study. BMJ 322:652-653
31. Szabo V, Borgulya G, Filkorn T, Majnik J, Banyasz I, Nagy ZZ 2007 The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy. Mol Vis 13:659-666
32. Encio IJ, Detera-Wadleigh SD 1991 The genomic structure of the human glucocorticoid receptor. J Biol Chem 266:7182-7188
33. Oakley RH, Jewell CM, Yudt MR, Bofetiado DM, Cidlowski JA 1999 The dominant negative activity of the human glucocorticoid receptor β isoform. Specificity and mechanisms of action. J Biol Chem 274:27857-27866
34. Oakley RH, Sar M, Cidlowski JA 1996 The human glucocorticoid receptor β isoform. Expression, biochemical properties, and putative function. J Biol Chem 271:9550-9559
35. Goleva E, Li LB, Eves PT, Strand MJ, Martin RJ, Leung DY 2006 Increased glucocorticoid receptor β alters steroid response in glucocorticoid-insensitive asthma. Am J Resp Crit Care Med 173:607-616
36. Koga Y, Matsuzaki A, Suminoe A, Hattori H, Kanemitsu S, Hara T 2005 Differential mRNA expression of glucocorticoid receptor α and β is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children. Pediatr Blood Cancer 45:121-127
37. Derijk RH, Schaaf MJ, Turner G, Datson NA, Vreugdenhil E, Cidlowski J, de Kloet ER, Emery P, Sternberg EM, Detera-Wadleigh SD 2001 A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor β-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol 28:2383-2388
38. Schaaf MJ, Cidlowski JA 2002 AUUUA motifs in the 3′UTR of human glucocorticoid receptor α and αa mRNA destabilize mRNA and decrease receptor protein expression. Steroids 67:627-636
39. van den Akker EL, Nouwen JL, Melles DC, van Rossum EF, Koper JW, Uitterlinden AG, Hofman A, Verbrugh HA, Pols HA, Lamberts SW, van Belkum A 2006 Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J Infect Dis 194:814-818
40. van den Akker EL, Koper JW, van Rossum EF, Dekker MJ, Russcher H, de Jong FH, Uitterlinden AG, Hofman A, Pols HA, Witteman JC, Lamberts SW 2008 Glucocorticoid receptor gene and risk of cardiovascular disease. Arch Intern Med 168:33-39